Inflammatix
  • TriVerity
  • Education
    • Acute Infection & Sepsis
    • Immune Response
    • Machine Learning
    • Advocacy
  • Evidence
    • Publications
    • Abstracts
  • Pipeline
  • News
    • News
    • Press Releases
    • ML Blogs
    • Podcasts
    • Media Contact
  • Careers
  • About
    • Leadership
    • Investors
    • Partner With Us
    • Awards
    • Certificates
  • Reach Out
Select Page
Do Your Genes Know What’s Making You Sick?

Do Your Genes Know What’s Making You Sick?

Jan 6, 2022

Artificial Intelligence for Clinical Decision Support in Sepsis

Artificial Intelligence for Clinical Decision Support in Sepsis

May 13, 2021

Inflammatix Checks off All the Right Boxes with Investors

Inflammatix Checks off All the Right Boxes with Investors

Mar 19, 2021

Inflammatix nets $102M to advance its immune system tests for infectious diseases

Inflammatix nets $102M to advance its immune system tests for infectious diseases

Mar 16, 2021

Infection-detection system from Peninsula company scores $102M, aims to hit market this year

Infection-detection system from Peninsula company scores $102M, aims to hit market this year

Mar 16, 2021

« Older Entries
Next Entries »
    • TriVerity
    • Education
      • Acute Infection & Sepsis
      • Immune Response
      • Machine Learning
      • Advocacy
    • Evidence
      • Publications
      • Abstracts
    • Pipeline
    • News
      • News
      • Press Releases
      • ML Blogs
      • Podcasts
      • Media Contact
    • Careers
    • About
      • Leadership
      • Investors
      • Partner With Us
      • Awards
      • Certificates
    • Reach Out

    © Copyright 2025, Inflammatix, Inc. All Rights Reserved | Terms & Conditions | Privacy & Cookies Statement
    Inflammatix, TriVerity, Myrna, RespVerity, and BacVerity are trademarks of Inflammatix, Inc.

    • Follow
    • Follow